ST岭南公告称，"岭南转债"无法按期兑付本息，其信用等级被下调为C。公司近年业务受冲击，营收持 续下滑，2024年营收8.62亿元，同比降59.55%，净亏9.84亿元，亏损缩窄9.86%；2025年1 - 9月营收2.53 亿元，同比降68.75%，净亏2.06亿元，亏损缩窄23.34%。公司还面临持续经营、增信计划抵质押资产变 现、股票退市、诉讼等风险。近日，因金融借款合同纠纷，公司和子公司被列为第三人涉诉，案件未开 庭，影响未知。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600187证券简称：国中水务 编号：临2025-041 黑龙江国中水务股份有限公司 关于参股公司涉及诉讼的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 案件所处的诉讼阶段：法院已受理。 ● 对上市公司损益产生的影响：本次案件尚未开庭审理，对公司本期利润或期后利润的影响存在不确定 性 近日，诸暨文盛汇收到北京市第三中级人民法院作出的（2025）京03民初2237号民事裁定书，因河北汇 源食品饮料有限公司与诸暨文盛汇、北京汇源合同纠纷一案，申请人河北汇源食品饮料有限公司向北京 市第三中级人民法院申请财产保全，请求对被申请人诸暨文盛汇名下价值1,012,650,000元的财产采取保 全措施。北京市第三中级人民法院作出准予保全的裁定并冻结了被申请人诸暨文盛汇持有的北京汇源的 60%股权（对应注册资本为640,451,784.72元，登记机关：北京市顺义区市场监督管理局）。冻结期限 不得超过三年。经了解，诸暨文盛汇本次涉及的诉讼情况具体如下： ...

长江商报消息 ●长江商报记者 沈右荣 近期风波不断的瑞茂通（600180.SH）风险进一步暴露。12月24日晚，公司公告，新增诉讼10.21亿元，被告均为 公司及旗下全资子公司。截至目前，累计发生尚未结案的诉讼涉案金额22.26亿元。 12月23日晚，瑞茂通披露了新增逾期债务4.64亿元。截至公告日，公司累计金融机构借款逾期与商业承兑汇票逾 期合计逾20亿元。 截至2025年9月末，瑞茂通资产负债率达74.29%，前三季度财务费用2.92亿元。 作为瑞茂通的实际控制人，万永兴及其一致行动人累计被轮候冻结股份41.02亿股，占其所持股份数的595.92%， 占瑞茂通总股本的377.51%。 瑞茂通的前身是九发股份，2011年，万永兴携瑞茂通借壳上市。2012年至2017年，瑞茂通持续盈利，且经营业绩 呈增长趋势。2018年开始，公司实现的归母净利润大幅波动，2022年以来，则持续下降。 从铁路职工逆袭成河南首富，低调多年的万永兴陷入了困境。 瑞茂通内部机制存在明显缺陷。公司自2015年起借用控股股东账户进行跨境资金结算长达7年未披露。 备受关注的是，12月4日以来，瑞茂通连收两份监管函，暴露出公司在信息披露等方 ...

瑞茂通供应链管理股份有限公司及旗下子公司新增金融机构借款逾期金额合计约为46,411.6876万元人民 币，商业承兑汇票逾期金额约为45,822.7018万元人民币，两项合计逾期约92,234.3894万元，占公司最近 一期经审计净资产的11.69%。子公司已归还逾期借款1,420万元，目前累计逾期总额约为200,148.8649万 元，占净资产比例为25.37%。公司可能面临诉讼、仲裁、账户冻结等风险，正积极协商解决。 瑞茂通关于公司及子公司新增诉讼的公告 交易信息汇总资金流向 12月24日主力资金净流出2004.69万元，占总成交额23.53%；游资资金净流入855.01万元，占总成交额 10.03%；散户资金净流入1149.68万元，占总成交额13.49%。 公司公告汇总瑞茂通关于部分债务逾期的进展公告 截至2025年12月24日收盘，瑞茂通(600180)报收于3.76元，下跌1.05%，换手率2.08%，成交量22.62万 手，成交额8520.75万元。 当日关注点 瑞茂通供应链管理股份有限公司及子公司近期新增多起诉讼案件，法院已立案但尚未开庭审理，公司为 被告方。涉案总金额约102,124.973 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000826 证券简称：启迪环境 公告编号：2025-090 启迪环境科技发展股份有限公司 关于涉及诉讼（仲裁）案件进展的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,公告不存在虚假记载、误导性陈述或者重 大遗漏。 重要提示： 1、截至目前，启迪环境科技发展股份有限公司（以下简称"公司"或"启迪环境"）及控股子公司因行政 诉讼、工程建设纠纷等经营事项提起诉讼累计未结、仲裁事项金额合计为6.13亿元；公司以及控股子公 司因建设工程施工合同纠纷、债权债务诉讼、涉及证券虚假陈述责任纠纷等事项为被告累计未结诉讼、 仲裁事项金额合计为44.13亿元。 公司及控股子公司累计诉讼、仲裁事项金额合计50.26亿元，占本公司最近一期经审计净资产的 209.27%。 2、前期部分公司及相关子公司被列为被告的涉诉案件已取得判决结果或达成和解，截至目前，待履行 金额合计约为72.33亿元。 公司目前总体涉诉及判决待履行金额较大，公司正积极推动强化应收账款催收及部分资产处置等措施解 决涉诉风险及后续判决履行压力。公司将根据诉讼进展情况依规履行信息披露义务，敬请投 ...

Core Viewpoint - The announcement details the recent legal disputes involving the company, including new lawsuits and ongoing cases, which may impact its financial performance. Group 1: New Major Litigation - The company has reported a new major lawsuit involving a guarantee contract dispute, with a claim amount of $1.8294 million, representing approximately 1.54% of the company's latest audited net assets [1][2][3]. Group 2: Details of New Lawsuit - The new lawsuit (case number: (2025)粤0391民初8366号) involves Hong Kong Nanxing Co., Ltd. and claims for advertising fees of $1,152,003.09, along with late fees and legal costs [2][3]. - The plaintiff asserts that Hong Kong Nanxing Co. has long overdue payments, constituting a breach of contract, and seeks immediate payment [2][3]. Group 3: Previous Major Litigation Updates - Ongoing litigation includes a case regarding equity transfer disputes, where the company claims a payment of RMB 139.52 million and associated penalties [4][5]. - The company has faced adverse rulings in previous cases, including a rejection of its claims in a first-instance judgment [6][7]. Group 4: Arbitration Cases - An arbitration case (case number: (2024)深国仲受6645号) involves a claim for RMB 142.6 million against the company and its affiliates for a debt guarantee [8][9]. - The arbitration ruling mandates the company to bear joint guarantee responsibilities for the debt owed by Shenzhen Global Easy Buy E-commerce Co., Ltd. [10][11]. Group 5: Other Litigation and Arbitration Matters - The company is involved in 22 other litigation and arbitration cases, with a total claim amount of approximately RMB 4.35 billion, of which RMB 641.23 million involves the company as the plaintiff [39]. - The company has previously recognized an estimated liability of RMB 334 million, which may impact its current and future profits [41]. Group 6: Financial Impact of Legal Matters - The anticipated impact on the company's current profits from these legal matters is estimated at approximately RMB 80 million, based on preliminary assessments [41].

Core Viewpoint - The company, Lifan Shuke Co., Ltd., is currently under investigation by the China Securities Regulatory Commission for alleged violations of information disclosure related to its periodic reports, which may lead to mandatory delisting if found guilty [1] Group 1: Litigation Overview - The company’s wholly-owned subsidiary, Lifan Shuke (Anhui) Information Technology Co., Ltd., has initiated a lawsuit against Harbin Institute of Technology Industrial Robot Co., Ltd. due to a sales contract dispute, with the amount in question being 61,221,213.77 yuan [1][2] - The first-instance court ruled that the evidence presented was insufficient to reflect the entire nature of the transaction, leading to the dismissal of the case [2][3] - The second-instance court upheld the first-instance ruling, stating that the case involved economic crime suspicions and should be handled based on the results of the ongoing criminal investigation [3][4] Group 2: Court Decisions and Implications - The Anhui Provincial High Court rejected the subsidiary's request for a retrial, affirming that the case's handling is contingent upon the outcome of the related criminal investigation [5][6] - The company retains the option to file a new lawsuit based on new facts that emerged after the second-instance ruling, as indicated by recent documents from the Harbin Public Security Bureau [6][7] - The impact of this litigation on the company's current and future profits remains uncertain due to its connection with the ongoing criminal investigation [7] Group 3: Other Legal Matters - As of the announcement date, the company has no other undisclosed significant litigation or arbitration matters [8] - The company will closely monitor the situation and fulfill its information disclosure obligations [8]

Core Viewpoint - Longzhou Co., Ltd. (龙洲股份) disclosed two significant lawsuits involving its subsidiary Dongguan Zhongqi Hongyuan Automobile Co., Ltd. (中汽宏远) due to sales contract disputes, with the cases currently in the first instance awaiting judgment [2][11]. Group 1: Lawsuit Details - Zhongqi Hongyuan is the defendant in two lawsuits filed by Dongguan Bus Co., Ltd. and Dongguan City Bus Transportation Co., Ltd., with the amounts involved being 205 million yuan and 226 million yuan respectively, totaling approximately 431 million yuan [8][10]. - The lawsuits stem from issues related to battery failures in electric buses sold by Zhongqi Hongyuan in 2018, which led to significant operational disruptions starting in 2021 [10][12]. Group 2: Company Actions and Financial Implications - Longzhou Co., Ltd. stated that Zhongqi Hongyuan has reached agreements with the plaintiffs regarding warranty and repair matters, and has completed the necessary maintenance work [11]. - The company has made provisions for the repair costs associated with the affected buses in the 2024 fiscal year [11]. - Longzhou Co., Ltd. reported that the total amount of other undisclosed minor lawsuits and arbitration matters is 83.2852 million yuan, accounting for 7.16% of the company's audited net assets for 2024 [11]. Group 3: Financial Performance - Longzhou Co., Ltd. has experienced three consecutive years of losses, with net losses reported at 79.2269 million yuan, 352 million yuan, and 348 million yuan for the years 2022 to 2024 [17]. - For the first three quarters of 2025, the company reported revenue of 1.825 billion yuan, a year-on-year decrease of 26.61%, and a net profit attributable to shareholders of -95.6357 million yuan, down 32.45% year-on-year [20].

Core Viewpoint - Longzhou Co., Ltd. (龙洲股份) disclosed two significant lawsuits involving its subsidiary Dongguan Zhongqi Hongyuan Automobile Co., Ltd. (中汽宏远) related to sales contract disputes, with a total claim amount of approximately 431 million yuan [1][2]. Group 1: Lawsuit Details - The lawsuits involve claims from Dongguan Bus Co., Ltd. and Dongguan City Bus Transportation Co., Ltd., with amounts of 205 million yuan and 226 million yuan respectively [1]. - The core issue stems from battery failures in electric buses sold by Zhongqi Hongyuan, with the first batch of 250 buses purchased in October 2018 experiencing issues starting from October 2021 [1][2]. - The second batch of 422 buses, purchased by Dongguan City Bus, began showing similar problems from January 2021, leading to operational halts [1]. Group 2: Legal Claims and Agreements - Both plaintiffs are demanding Zhongqi Hongyuan to fulfill warranty obligations and compensate for operational losses due to the vehicle failures, along with covering legal fees and other related costs [2]. - Zhongqi Hongyuan has reached agreements with the plaintiffs regarding warranty and repair matters, and has completed the necessary maintenance work [2]. - Longzhou Co., Ltd. plans to pursue compensation from Weihong Company (微宏公司) for the repair costs and operational losses incurred due to the battery issues [2]. Group 3: Financial Impact and Other Legal Matters - As of the announcement date, the company and its subsidiaries have other minor litigation and arbitration matters totaling 83.2852 million yuan, representing 7.16% of the audited net assets for 2024 [3]. - The company stated that the impact of the lawsuits on its financial performance remains uncertain until a judgment is reached [3].

Core Viewpoint - The stock price of Zhongzhu Medical Holdings Co., Ltd. has experienced significant fluctuations, prompting a risk warning for investors regarding trading in the secondary market [1][2]. Shareholder Equity Change Risk - Major shareholders, Guangzhou Yunying Capital Management Co., Ltd. and Zheng Zixian, have signed a share transfer agreement with Meihua Investment, transferring a total of 206,821,844 shares at a price of 1.95 yuan per share, which constitutes 10.38% of the company's total share capital [1][2]. Performance Loss Risk - The company has reported negative net profits for three consecutive fiscal years, with a net profit of -623.87 million yuan for the year 2024 and a net profit of -33.79 million yuan for the first three quarters of 2025 [3][4]. Litigation Risk - Zhongzhu Jun Tian (Beijing) Medical Technology Co., Ltd. is involved in a legal dispute regarding a lease contract with Hongjie Runzhong Consulting Co., Ltd., which has resulted in a court ruling declaring the lease contract invalid [4][5][6]. - The company has initiated legal proceedings against Hongjie Runzhong and Gao Xin Investment for damages related to the invalid lease contract, with a claimed amount of 402.05 million yuan [6][7]. Performance Commitment Risk - The company has filed lawsuits against several parties for failing to meet performance commitments, resulting in a court ruling for compensation in shares and dividends totaling 17,423,025 shares and 435,575.63 yuan [8][9]. Fund Occupation Risk - As of the end of 2024, Zhongzhu Group and its affiliates have an outstanding fund occupation balance of 567.99 million yuan, with ongoing legal actions to recover the owed amounts [10][11]. Continued Risk Warning - The company's stock continues to be subject to risk warnings due to unresolved fund occupation issues, as per the Shanghai Stock Exchange regulations [12].